Uteron Pharma : Research for woman future Uteron Pharma : Research for woman future Uteron Pharma : Research for woman future
> Latest news > Uteron Pharma is contemplating a public offering to finance the (...)
Uteron Pharma : Research for woman future

2013/01/23 : Watson Acquires Uteron Pharma

Read more


2012/05/2 : Uteron Pharma is contemplating a public offering to finance the (...)

Read more


2012/04/24 : Professor Jean-Michel Foidart has been awarded the Bologne-Lemaire (...)

Read more



Uteron Pharma : Research for woman future

Latest news

May 2 2012 : Uteron Pharma is contemplating a public offering to finance the development of its product portfolio

Following the successful completion of a 14 million EUR capital raise in April 2012, Uteron Pharma continues to evaluate its options for future funding of its product portfolio. A public offering is being considered.

Upload file(s)

 Uteron Pharma is contemplating a public offering to finance the development of its product portfolio (EN)

 Uteron Pharma envisage une introduction en bourse pour financer le développement de sa gamme de produits (FR)






© 2011 Uteron Pharma - Legal - Privacy policy Designed and Powered by Lusis Communication

Company

Background
History
Location
Contact us

Products

Levosert™
Diafert™

Production

Market

Newsroom

Uteron Pharma : Research for woman future